P&G Defends Tooth Whitening Cosmetic Classification In FDA Letter
This article was originally published in The Tan Sheet
Executive Summary
Procter & Gamble urges FDA to deny a citizen petition by the American Dental Association to reclassify commercially available tooth-whiteners as drugs, saying ADA members' financial interests motivated the petition
You may also be interested in...
Consumer Tooth Whiteners Belong In Homes; FDA Denies ADA Petition For Drug Status
The American Dental Association’s 2009 petition does not support a drug designation for peroxide-containing tooth-whitening products, FDA responds. Further information is needed on formulations, mechanisms of action and safety profiles for FDA to determine whether the products meet the definition of a drug.
Consumer Tooth Whiteners Belong In Homes; FDA Denies ADA Petition For Drug Status
The American Dental Association’s 2009 petition does not support a drug designation for peroxide-containing tooth-whitening products, FDA responds. Further information is needed on formulations, mechanisms of action and safety profiles for FDA to determine whether the products meet the definition of a drug.
Dental Association Petitions FDA To Evaluate Tooth Whitening Treatments
The American Dental Association asks FDA to follow through on its promise to evaluate the safety of the rapidly increasing number of tooth bleaching products and classify their regulatory status